This memorandum is intended to provide clarification on the applicability of two DHHS final regulations to the WIC program. These regulations include requirements for: (1) the establishment of standard formats for certain administrative and financial transactions, and (2) the privacy of individually identifiable health information.
This final rule delays from Feb. 27, 2002 until Oct. 1, 2002 the implementation date of the final rule entitled Special Supplemental Nutrition Program for Women, Infants and Children: Food Delivery Systems, which was published in the Federal Register on Dec. 29, 2000, 65 FR 83248, and became effective on April 28, 2001.
The purpose of this policy memorandum is to advise that the Medicaid Program will be the primary payor for WIC-eligible exempt infant formulas and medical foods issued to WIC participants who are also Medicaid beneficiaries.
This proposed rule would delay the implementation date of the final rule entitled Special Supplemental Nutrition Program for Women, Infants and Children: Food Delivery Systems, published in the Federal Register on Dec. 29, 2000, 65 FR 83248, which became effective on April 28, 2001 and has an implementation date of Feb. 27, 2002.
The purpose of this memorandum is to answer questions regarding the requirement at section 226.16(b) that state agencies approve sponsored facilities’ applications for participation in CACFP, and the timing of the initial reimbursements to sponsored facilities in CACFP.
The purpose of this memorandum is to provide an update on the Department of Defense actions to implement a program like WIC overseas, the impact it has on the WIC program, and the actions required by WIC state agencies.
This action temporarily delays for 60 days the effective date of the rule entitled WIC Food Delivery Systems, published in the Federal Register on Dec. 29, 2000, 65 FR 83248.
Since the publication of the “WIC Bloodwork Requirements” final rule in December 1999, several questions have arisen that require clarification. Therefore, the purpose of this policy memorandum is to clarify these questions as well as provide an update on the status of all policy memoranda previously issued that address bloodwork requirements.